Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by lscfaon May 25, 2023 4:08pm
110 Views
Post# 35464514

RE:New Press Release - Ceapro Inc. Reports Financial Results for First Quarter 2023 and Provides Corporate Update

RE:New Press Release - Ceapro Inc. Reports Financial Results for First Quarter 2023 and Provides Corporate UpdateMaybe if Gagnon did not have the base business cash flow he would be more prudent in spending. G&A blowing up...

 

 

Revenues

Gross profit

Gross margin

Cash flow ops

R&D

G&A

CFO b/f R&D

Q1 23

3,494,811

1,605,838

45.9%

162738

573,687

1,521,445

736,425

Q4 22

3,322,214

1,345,785

40.5%

500,826

575,211

993,068

1,076,037

Q3 22

3,845,370

2,077,970

54.0%

1,637,402

314,250

869,110

1,951,652

Q2 22

5,500,399

3,639,335

66.2%

2,678,299

543,924

1,069,275

3,222,223

Q1 22

6,171,624

3,954,609

64.1%

3,091,281

355,281

769,045

3,446,562

Q4 21

3,531,975

1,843,547

52.2%

816,455

728,558

808,013

1,545,013

Q3 21

4,552,980

2,949,325

64.8%

1,351,110

1,403,186

766,605

2,754,296

Q2 21

4,408,631

2,638,478

59.8%

1,151,609

830,511

952,847

1,982,120

Q1 21

4,701,743

2,257,943

48.0%

989,515

816,847

712,207

1,806,362

 

<< Previous
Bullboard Posts
Next >>